| Medical Condition | Atrial Fibrillation |
| Facility/Clinic | Accellacare – 1202 Medical Center Dr |
| Age | 18 years and older |
| Gender | Male & Female |
| Description | The purpose of this study is to compare the effects of an experimental drug, Milvexian, to the comparator drug, Apixaban (Eliquis) to determine if it is safe and useful in reducing the risk of stroke and blood clots outside the brain in participants with atrial fibrillation. |
| Enrollment | Open |
| Patient Commitment Duration | 3.5-4 years |
| Number of visits in study | Up to 15 visits |
| Patient Compensation | $100 per visit |
The team at WH Research can guide interested clinical research participants through the process of enrolling in a trial.
Please call 910-799-5500 between the hours of 8am-5pm for general research questions.